Research Analysts’ price target changes for Tuesday, August 25th:
ACADIA Pharmaceuticals (NASDAQ:ACAD) had its target price raised by Citigroup Inc. from $39.00 to $40.00. The firm currently has a buy rating on the stock.
AECOM (NYSE:ACM) had its price target trimmed by Argus from $85.00 to $75.00. They currently have a buy rating on the stock.
Applied Materials (NASDAQ:AMAT) had its target price reduced by Mizuho from $650.00 to $590.00. The firm currently has an outperform rating on the stock.
BXP (NYSE:BXP) had its price target increased by JPMorgan Chase & Co. from $79.00 to $87.00. The firm currently has an overweight rating on the stock.
Chime Financial (NASDAQ:CHYM) had its price target increased by Wolfe Research from $32.00 to $38.00. Wolfe Research currently has an outperform rating on the stock.
Chime Financial (NASDAQ:CHYM) had its price target boosted by Wells Fargo & Company from $33.00 to $39.00. They currently have an overweight rating on the stock.
Coinbase Global (NASDAQ:COIN) had its price target raised by The Goldman Sachs Group, Inc. from $173.00 to $196.00. The firm currently has a buy rating on the stock.
Dollar Tree (NASDAQ:DLTR) had its target price raised by Truist Financial Corporation from $136.00 to $138.00. They currently have a buy rating on the stock.
Euronet Worldwide (NASDAQ:EEFT) had its target price trimmed by Wolfe Research from $75.00 to $70.00. The firm currently has an underperform rating on the stock.
Elastic (NYSE:ESTC) had its target price raised by Wells Fargo & Company from $60.00 to $80.00. The firm currently has an equal weight rating on the stock.
eToro Group (NASDAQ:ETOR) had its target price cut by The Goldman Sachs Group, Inc. from $36.00 to $32.00. The firm currently has a neutral rating on the stock.
EVgo (NASDAQ:EVGO) had its price target cut by Stifel Nicolaus from $7.00 to $6.00. The firm currently has a buy rating on the stock.
Expedia Group (NASDAQ:EXPE) had its price target boosted by BTIG Research from $350.00 to $400.00. BTIG Research currently has a buy rating on the stock.
Fidelity National Information Services (NYSE:FIS) had its target price raised by Wolfe Research from $53.00 to $54.00. Wolfe Research currently has an outperform rating on the stock.
Five Below (NASDAQ:FIVE) had its target price raised by Truist Financial Corporation from $265.00 to $273.00. Truist Financial Corporation currently has a buy rating on the stock.
Five9 (NASDAQ:FIVN) had its price target raised by Wells Fargo & Company from $24.00 to $32.00. The firm currently has an equal weight rating on the stock.
Global-e Online (NASDAQ:GLBE) had its target price increased by Truist Financial Corporation from $41.00 to $47.00. Truist Financial Corporation currently has a buy rating on the stock.
Global Payments (NYSE:GPN) had its target price raised by Truist Financial Corporation from $79.00 to $95.00. The firm currently has a hold rating on the stock.
Hikma Pharmaceuticals (LON:HIK) had its price target boosted by Jefferies Financial Group Inc. from GBX 1,870 to GBX 2,025. Jefferies Financial Group Inc. currently has a buy rating on the stock.
Invitation Home (NYSE:INVH) had its target price increased by JPMorgan Chase & Co. from $33.00 to $34.00. They currently have an overweight rating on the stock.
Kardigan (NASDAQ:KARD) had its price target cut by JPMorgan Chase & Co. from $51.00 to $46.00. The firm currently has an overweight rating on the stock.
Strix Group (LON:KETL) had its target price trimmed by Berenberg Bank from GBX 70 to GBX 65. The firm currently has a buy rating on the stock.
Kimco Realty (NYSE:KIM) had its price target increased by JPMorgan Chase & Co. from $25.00 to $26.00. They currently have a neutral rating on the stock.
Joint Stock Company Kaspi.kz (NASDAQ:KSPI) had its target price increased by Wolfe Research from $110.00 to $115.00. Wolfe Research currently has an outperform rating on the stock.
Centrus Energy (NYSE:LEU) had its price target cut by Stifel Nicolaus from $246.00 to $216.00. The firm currently has a buy rating on the stock.
Lam Research (NASDAQ:LRCX) had its price target cut by Mizuho from $370.00 to $365.00. They currently have an outperform rating on the stock.
lululemon athletica (NASDAQ:LULU) had its target price trimmed by UBS Group AG from $124.00 to $120.00. They currently have a neutral rating on the stock.
MongoDB (NASDAQ:MDB) had its target price boosted by Robert W. Baird from $335.00 to $400.00. Robert W. Baird currently has a neutral rating on the stock.
Marks and Spencer Group (LON:MKS) had its price target increased by Citigroup Inc. from GBX 390 to GBX 470. They currently have a buy rating on the stock.
MKS (NASDAQ:MKSI) had its target price reduced by Mizuho from $360.00 to $330.00. The firm currently has an outperform rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its target price increased by Argus from $145.00 to $170.00. They currently have a buy rating on the stock.
Merck & Co., Inc. (NYSE:MRK) had its price target raised by Wolfe Research from $155.00 to $180.00. Wolfe Research currently has an outperform rating on the stock.
Marvell Technology (NASDAQ:MRVL) had its target price boosted by Susquehanna from $230.00 to $265.00. The firm currently has a positive rating on the stock.
Marvell Technology (NASDAQ:MRVL) had its target price raised by Rosenblatt Securities from $240.00 to $300.00. Rosenblatt Securities currently has a buy rating on the stock.
Strategy (NASDAQ:MSTR) had its price target boosted by Canaccord Genuity Group Inc. from $130.00 to $175.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Micron Technology (NASDAQ:MU) had its price target cut by Mizuho from $1,375.00 to $1,300.00. The firm currently has an outperform rating on the stock.
Nutanix (NASDAQ:NTNX) had its price target increased by Rosenblatt Securities from $60.00 to $75.00. The firm currently has a buy rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price raised by Raymond James Financial, Inc. from $330.00 to $352.00. They currently have a strong-buy rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its price target raised by JPMorgan Chase & Co. from $326.00 to $384.00. The firm currently has an overweight rating on the stock.
Paycom Software (NYSE:PAYC) had its target price increased by JPMorgan Chase & Co. from $140.00 to $264.00. The firm currently has a neutral rating on the stock.
PDD (NASDAQ:PDD) had its target price lowered by Benchmark Co. from $127.00 to $114.00. The firm currently has a buy rating on the stock.
PICS (NASDAQ:PICS) had its target price lowered by Royal Bank Of Canada from $18.00 to $16.00. The firm currently has an outperform rating on the stock.
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its target price raised by JPMorgan Chase & Co. from $75.00 to $80.00. They currently have an overweight rating on the stock.
Rubrik (NYSE:RBRK) had its target price increased by Scotiabank from $95.00 to $114.00. They currently have a sector outperform rating on the stock.
REGENXBIO (NASDAQ:RGNX) had its price target cut by Robert W. Baird from $32.00 to $29.00. Robert W. Baird currently has an outperform rating on the stock.
REGENXBIO (NASDAQ:RGNX) had its target price trimmed by HC Wainwright from $23.00 to $21.00. The firm currently has a buy rating on the stock.
SL Green Realty (NYSE:SLG) had its target price raised by JPMorgan Chase & Co. from $51.00 to $61.00. They currently have a neutral rating on the stock.
Sandisk (NASDAQ:SNDK) had its target price cut by Mizuho from $1,900.00 to $1,875.00. The firm currently has an outperform rating on the stock.
Snowflake (NYSE:SNOW) had its price target raised by Robert W. Baird from $280.00 to $350.00. Robert W. Baird currently has an outperform rating on the stock.
Synchrony Financial (NYSE:SYF) had its target price raised by Wolfe Research from $85.00 to $90.00. They currently have an outperform rating on the stock.
Teleflex (NYSE:TFX) had its target price raised by Needham & Company LLC from $159.00 to $170.00. Needham & Company LLC currently has a buy rating on the stock.
Workday (NASDAQ:WDAY) had its price target boosted by Canaccord Genuity Group Inc. from $200.00 to $225.00. The firm currently has a buy rating on the stock.
XPENG (NYSE:XPEV) had its price target trimmed by JPMorgan Chase & Co. from $27.00 to $24.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Receive News & Ratings for ACADIA Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACADIA Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
